Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing antimicrobial dosing in the critically ill patient.

John Goldberg1, Robert C Owens

  • 1Department of Medicine, Division of Infectious Diseases, and Division of Critical Care Pharmacology, Maine Medical Center, Portland, Maine 04102, USA.

Current Opinion in Critical Care
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020.

Journal of translational medicine·2021
Same author

Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.

Sarcoma·2020
Same author

A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies.

Pediatric hematology and oncology·2020
Same author

A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin.

Pediatric blood & cancer·2018
Same author

Pharmacokinetics-pharmacodynamics, computer decision support technologies, and antimicrobial stewardship: the compass and rudder.

Diagnostic microbiology and infectious disease·2018
Same author

Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.

Pediatric hematology and oncology·2017
Same journal

How to establish and run a national ICU benchmarking registry.

Current opinion in critical care·2026
Same journal

Cardiogenic shock - toward phenotype-directed, precision management.

Current opinion in critical care·2026
Same journal

The future of critical care nutrition: from calorie counting to precision personalized metabolism therapy.

Current opinion in critical care·2026
Same journal

Editorial introduction.

Current opinion in critical care·2026
Same journal

Generative artificial intelligence for outcome prediction in critical care: the future is now?

Current opinion in critical care·2026
Same journal

Feeding under support in critical care illness: metabolic and nutritional management during extracorporeal membrane oxygenation and continuous renal replacement therapy.

Current opinion in critical care·2026
See all related articles

Optimizing antibiotic dosing in critically ill patients uses pharmacodynamics for evidence-based strategies. This approach considers patient factors, minimizes adverse events, and reduces resistance and costs for effective treatment.

Area of Science:

  • Pharmacology
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Historically, antibiotic dosing lacked precise scientific basis.
  • Pharmacodynamics is emerging as a key science to guide antimicrobial selection and dosing.
  • Optimizing antimicrobial therapy is crucial, especially in critically ill patients.

Purpose of the Study:

  • To review principles for optimizing antimicrobial dosing in critically ill patients.
  • To discuss recent data on applying these principles.
  • To move towards evidence-based optimal dosing strategies.

Main Methods:

  • Review of scientific literature and clinical data on antimicrobial pharmacodynamics.
  • Analysis of factors influencing optimal dosing in critical care.

Related Experiment Videos

  • Consideration of patient-specific variables (weight, age, renal replacement therapy).

    • Main Results:

    • Shift from arbitrary dosing to evidence-based strategies.
    • Importance of selecting appropriate regimens active against pathogens.
    • Need to consider adverse events, resistance, duration, patient variables, and cost.

    Conclusions:

    • Optimizing antimicrobial therapy requires more than just dose selection.
    • Evidence-based dosing strategies are essential for critically ill patients.
    • A comprehensive approach considering efficacy, safety, resistance, and cost is necessary.